Elsevier Launches Molecular Oncology
Elsevier announced today the inaugural issue of a new journal, Molecular Oncology – a journal for discovery-driven translational cancer research, published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS). The quarterly journal will focus on the advances in the rapidly expanding field of molecular oncology. The first issue will appear online today and be available in print in the first week of June 2007.
Prof. Julio E.Celis, Scientific Director of the Institute of Cancer Biology at the Danish Cancer Society in Copenhagen, will be the founding Editor-in-Chief of the new journal. A prestigious international Board of Editors including Profs. Mariano Barbacid, Minna Bissell, Peter Boyle, Tony Hunter, John Mendelsohn, Joan Massague, Richard Schilsky, Jane Visvader, Hironobu Sasano, and Axel Ullrich, who will be actively involved in developing the editorial policy of the journal.
Molecular Oncology will highlight new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal will be to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.
Editor-in-Chief Prof. Julio E. Celis explains: “The completion of the human genome project, as well as the current availability of novel and powerful technologies within genomics, proteomics and functional genomics promise to have a major impact on clinical practice, as these developments are likely to change the way in which cancer will be diagnosed, treated and monitored in the future.The greatest challenge today is how to effectively bridge basic and clinical cancer research in order to expedite the translation of novel discoveries into clinical applications for the benefit of the patient.”
“The Danish Cancer Society with its 380,000 members, and various patient support and research departments is proud to host the Editorial Office of this exciting new journal in cancer”, states A. Rohliged, Director, and former Minister of Health in Denmark.
Elsevier’s presence in the field of oncology with leading titles such as Cancer Cell, The Lancet Oncology, European Journal of Cancer, BBA Reviews on Cancer and many additional journals of high prestige, continues to expand to keep pace with growing interest in the topic. Elsevier is proud to be partnering with one of the leading life science federations in Europe on this new journal.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.